Thu, May 12, 2022
Wed, May 11, 2022
Tue, May 10, 2022

Puneet Souda Maintained (ABCL) at Buy with Decreased Target to $14 on, May 11th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-14-on-may-11th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Puneet Souda of SVB Leerink, Maintained "AbCellera Biologics Inc." (ABCL) at Buy with Decreased Target from $20 to $14 on, May 11th, 2022.

Puneet has made no other calls on ABCL in the last 4 months.



There is 1 other peer that has a rating on ABCL. Out of the 1 peers that are also analyzing ABCL, 0 agree with Puneet's Rating of Hold.



This is the rating of the analyst that currently disagrees with Puneet


  • Tiago Fauth of "Credit Suisse" Maintained at Buy with Increased Target to $40 on, Friday, February 25th, 2022

Publication Contributing Sources